RALEIGH, NC, August 2, 2023, ProPharma Group (ProPharma), the leading global provider of regulatory, clinical, and compliance services for the life sciences industry, and a portfolio company of Odyssey Investment Partners, today announced the appointment of Helen Hall as Global Head of Clinical Data Sciences, where she will lead clinical data management, as well as biostatistics and programming.
A seasoned leader in clinical research with over two decades of progressive experience, Hall brings an extensive knowledge base, renowned expertise, and a commendable track record of producing organizational and operational outcomes for globally recognized life sciences organizations. Prior to joining ProPharma, the world's largest RCO (Research Consulting Organization), Hall served in several senior leadership capacities at Syneos Health (Synteract), most recently as Senior Vice President, Clinical Data Sciences and Biometrics.
Throughout her distinguished career, Hall has demonstrated exemplary leadership to achieve corporate, operational, and financial goals while strictly adhering to regulatory, Good Clinical Practice (GCP), Standard Operating Procedures (SOPs), and protocol requirements. Her countless achievements managing diverse teams of data sciences and biometrics professionals, domestically and internationally, has enabled the cultivation of a collaborative, productive, and efficient atmosphere that is conducive to long-term and future-focused organizational growth.
Michael Stomberg, ProPharma's Chief Executive Officer, said: "We are excited to welcome Helen to the team. Her proven history of driving successful results, combined with her industry expertise and acumen make her an ideal match for this pivotal role. Helen's demonstrated leadership in data sciences, organizational transformation, team development, process creation and harmonization, and strategic client management fortify ProPharma's commitment to improve the health and safety of patients."
Upon her appointment, Hall shared, "I am thrilled to join ProPharma and leverage my experience in clinical research, data sciences, and biometrics to propel the company's strategic objectives. I am eager to partner with ProPharma's global team to ensure superior clinical data science solutions are delivered to our valued client partners, further enhancing our position as the global leader in the life sciences sector."
ProPharma's steadfast commitment to innovation and the ongoing advancement of its revolutionary Research Consulting Organization (RCO) model is reaffirmed with the appointment of Hall as the Global Head of Clinical Data Sciences. This strategic move ensures robust leadership and positions the organization to surpass its operational and financial targets through the delivery of unparalleled clinical data sciences worldwide.
###
Media Inquiries and Contacts:
Zosya Popik Vice President, Global Marketing
ProPharma
zosya.popik@propharmagroup.com
Steve Rensi Senior Director, Global Brand Strategy & Communications
ProPharma
steve.rensi@propharmagroup.com
Jason Wakeford Senior Vice President, Communications
Clarity for ProPharma
propharma@clarity.global
